VNDD
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ
<Return to Disease List
Gangliosidosis Type II (GM2/Tay-Sachs Disease)
  • Description
  • Signalment
  • Clinical Features
  • Neurolocalization
  • Genetics
<
>
Gangliosidosis (GM2) is a deficiency in the enzyme beta-galactosidase which causes defects in the catabolism of gangliosides resulting in their accumulation in neuronal lysosomes.
Age of Onset:  Less than 18 months of age
Sex Predisposition: Any sex of animal can be affected
Clinical Course:
​Clinical signs worsen over time
Clinical Signs:
Behavioral/Mental Awareness 
Drowsiness
Anxiety
Decreased responsiveness to verbal commands

Posture and Appearance 
Wide-based stance in all limbs
Altered tail carriage – tail down

Movement 
Stiff gait
Hypermetria 

Falling
Ataxia
Tetraparesis
Intention tremor
Inability to climb up or down stairs

Proprioception
Hypermetric Postural Reactions

Cranial Nerves 
Decreased bilateral corneal reflex
Decreased/Absent bilateral menace response
Impaired vision
Ventrolateral strabismus


Special Functions (e.g. respiration; urination) 
Vomiting
Inappetence​
Brain and spinal cord
Associated with a HEXA missense mutation

For breed specific genetic testing, follow the links below:
https://www.genomia.cz/en/test/gm2-japan-chin/
https://www.kokogenetics.com/en/results/pet-health-test/gm2-gangliosidosis-japanese-chin?srsltid=AfmBOorQTK8TPy3tphRB0HO4MzztItPTmItTMP_xHpNB7AvbsfdfICMe
​https://www.wisdompanel.com/en-us/dog-health-conditions/gm2-gangliosidosis-chin
To read more about this disease click below:
References
Picture
Contact us:
[email protected]

Privacy Policy
Terms and Conditions​
Disclaimer
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ